Tag: NeVa
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Vesalio appoints VP of US sales, announces publication of “impressive” first-pass...
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution...
Vesalio gains CE-mark approval for new “one-of-a-kind” NeVa NET thrombectomy device
Vesalio has today announced receipt of CE-mark approval for commercialisation of its new NeVa NET, which the company claims is the “first and only”...
Vesalio announces oversubscribed Class A financing
Vesalio recently announced that it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors,...
Vesalio announces completion of enrolment in acute ischaemic stroke IDE study
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...
Vesalio secures Class A funding to bolster stroke treatment portfolio
Vesalio has successfully secured a Class A financing round. The company claims this funding will be utilised to support its ongoing US Investigational Device...
Vesalio obtains additional CE approval for new products with NeVa clinical...
Vesalio has announced that it has obtained its second CE approval spanning multiple new NeVa product designs and technology. The new generation NeVa devices...
Vesalio secures US$5 million investment capital funding
Vesalio announces it has recently raised US$5 million in funding. The capital will support the continued global expansion of the NeVa Neurothrombectomy System, finance...
Vesalio initiates full commercial launch of NeVa
NeVa next-generation neurothrombectomy system
Vesalio has announced that it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual...
Vesalio reports expansion of commercial distribution and additional published data on...
Vesalio has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System, it has...
